Literature DB >> 10950879

X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology.

S D Styren1, R L Hamilton, G C Styren, W E Klunk.   

Abstract

X-34, a lipophilic, highly fluorescent derivative of Congo red, was examined as a histochemical stain for pathological changes in Alzheimer's disease (AD). X-34 intensely stained neuritic and diffuse plaques, neurofibrillary tangles (NFTs), neuropil threads, and cerebrovascular amyloid. Comparison to standard methods of demonstrating AD pathology showed that X-34 correlated well with Bielschowsky and thioflavin-S staining. X-34 staining of NFTs correlated closely with anti-TAU antibody staining. A 1:1 correspondence of X-34 and anti-A beta antibody staining of plaques and cerebrovascular amyloid was observed. Both X-34 and thioflavin-S staining were eliminated by formic acid pretreatment, suggesting that beta-sheet secondary protein structure is a necessary determinant of staining. X-34 may be a general amyloid stain, like Congo red, because it also stains systemic amyloid deposits due to lambda-light chain monoclonal gammopathy. In conclusion, X-34 is a highly fluorescent marker for beta-sheet structures and intensely labels amyloid plaques, NFTs, neuropil threads, and vascular amyloid in AD brains. It can be used with both paraffin-embedded and frozen tissues as well as in combination with immunohistochemistry for double labeling. The intensity of staining and the simplicity and reproducibility of the technique suggest that it may be a useful addition to the standard techniques for evaluation of AD neuropathology. (J Histochem Cytochem 48:1223-1232, 2000)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10950879     DOI: 10.1177/002215540004800906

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  76 in total

Review 1.  In vivo amyloid imaging in Alzheimer's disease.

Authors:  H I Sair; P M Doraiswamy; J R Petrella
Journal:  Neuroradiology       Date:  2004-01-23       Impact factor: 2.804

2.  Anti-Amyloid Effects of Small Molecule Aβ-Binding Agents in PS1/APP Mice.

Authors:  A D Cohen; M D Ikonomovic; E E Abrahamson; W R Paljug; S T Dekosky; I M Lefterov; R P Koldamova; L Shao; M L Debnath; N S Mason; C A Mathis; W E Klunk
Journal:  Lett Drug Des Discov       Date:  2009-09       Impact factor: 1.150

3.  Effects of Congo red on aβ(1-40) fibril formation process and morphology.

Authors:  Partha Pratim Bose; Urmimala Chatterjee; Ling Xie; Jan Johansson; Emmanuelle Göthelid; Per I Arvidsson
Journal:  ACS Chem Neurosci       Date:  2010-02-03       Impact factor: 4.418

4.  Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.

Authors:  Katsuyoshi Mizukami; Hiroyasu Akatsu; Eric E Abrahamson; Zhiping Mi; Milos D Ikonomovic
Journal:  Neuropathology       Date:  2015-08-21       Impact factor: 1.906

5.  Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study.

Authors:  Milos D Ikonomovic; Eric E Abrahamson; Julie C Price; Ronald L Hamilton; Chester A Mathis; William R Paljug; Manik L Debnath; Anne D Cohen; Katsuyoshi Mizukami; Steven T DeKosky; Oscar L Lopez; William E Klunk
Journal:  Acta Neuropathol       Date:  2012-01-24       Impact factor: 17.088

6.  Imaging of CNS myelin by positron-emission tomography.

Authors:  Bruno Stankoff; Yanming Wang; Michel Bottlaender; Marie-Stephane Aigrot; Frederic Dolle; Chunying Wu; Douglas Feinstein; Guo-Feng Huang; Frank Semah; Chester A Mathis; William Klunk; Robert M Gould; Catherine Lubetzki; Bernard Zalc
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

7.  Phenolic bis-styrylbenzenes as β-amyloid binding ligands and free radical scavengers.

Authors:  Daniel P Flaherty; Tomomi Kiyota; Yuxiang Dong; Tsuneya Ikezu; Jonathan L Vennerstrom
Journal:  J Med Chem       Date:  2010-11-01       Impact factor: 7.446

8.  Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of β-amyloidosis.

Authors:  Tien-Phat V Huynh; Fan Liao; Caroline M Francis; Grace O Robinson; Javier Remolina Serrano; Hong Jiang; Joseph Roh; Mary Beth Finn; Patrick M Sullivan; Thomas J Esparza; Floy R Stewart; Thomas E Mahan; Jason D Ulrich; Tracy Cole; David M Holtzman
Journal:  Neuron       Date:  2017-12-06       Impact factor: 17.173

Review 9.  Amyloid imaging of Alzheimer's disease using Pittsburgh Compound B.

Authors:  Keith A Johnson
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

10.  Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls.

Authors:  Thomas J Esparza; Hanzhi Zhao; John R Cirrito; Nigel J Cairns; Randall J Bateman; David M Holtzman; David L Brody
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.